The role of adrenal catecholamines (CAs) was investigated with regard to the etiology of hypertension and cerebral stroke in the spontaneously hypertensive rats-stroke prone (SHRSP). The adrenal CAs in SHRSP were measured by high performance liquid chromatography with an electrochemical detector or by gas-liquid chromatography with an electron capture detector and the findings were compared with those in the spontaneously hypertensive rats (SHR) and Wistar-Kyoto strain (WKY). It has been proposed that the facilitation of peripheral sympathetic norepinephrine (NE) neurons in the young animals may act as a trigger in the development of hypertension in the SHR. This was verified by estimating the adrenal NE contents in both SHRSP and SHR at 4 weeks of age. A deficiency in adrenal dopamine (DA) in 4-week-old SHRSP was also observed. This deficiency may contribute to the facilitation of the adrenal NE cell. SHRSP was clearly distinguished from SHR by comparing the adrenal catecholamine contents of each strain. The contents of all three CAs in SHRSP were similar to those in WKY during the development of hypertension, while the contents of epinephrine and DA in the SHR were much higher than those in the WKY. Only in SHRSP did the contents of all three CAs increase rapidly after the development of hypertension. These rapid increases may be related to stroke.
T HE role of the central and the peripheral catecholaminergic structure in experimental hypertension, particulary in the spontaneously hypertensive rats (SHR), has been investigated extensively. In SHR, the facilitation of the peripheral sympathetic nervous system, as related to central abnormalities, is considered to be closely related to the development of hypertension. Here, the adrenal medulla is one of the most important peripheral sympathetic organs and is a major source of the circulating catecholamines (CAs) in rats. Nagatsu et al1) reported that both young and adult SHR had higher activities of catecholamine (CA) synthesizing enzymes in the adrenal grands than did age matched normotensive Wistar rats (NWR). Morisawa2) reported that the areas of norepinephrine (NE)-storing cell islets in the adrenal medulla of young and adult SHR were twice as large as those of WistarKyoto strain (WKY). Ozaki et al3) and others4) reported the NE content in SHR was twice as high as in WKY. However, there are conflicting reports with regard to epinephrine (E) contents of SHR and WKY.3),4) There are few reports on the dopamine (DA) levels in the adrenal glands of SHR, as separation from other CAs in these tissues is most difficult. In one of few observations on the adrenal medulla in the SHR-stroke prone (SHRSP), Nagatsu et al5) reported that the tyrosine hydroxylase activity in SHRSP at 16 weeks of age was higher than in SHR. In SHR, the inhibitors of CA synthesizing enzymes have a more pronounced hypotensive effect than is seen in NWR1),6) when these activities are higher in the adrenal glands in SHR than in NWR. On the other hand, performance of bilateral adrenal demedullation before the onset of hypertension in SHR does not delay the onset.7) Accordingly, the role of adrenal medullary CAs in the development and the maintenance of hypertension in SHR and SHRSP remains unclear. With recent developments in sensitive assay methods for CAs, such as a gas-liquid chromatograph with an electron capture detector (GLC-ECD),8) a radio enzymatic assay9) and high performance liquid chromatograph with an electrochemical detector (HPLC-EC),10) E, NE, and DA can be simultaneously determined in various peripheral tissues. In the present studies, we measured the CA contents, including DA, of the adrenal glands before, during and after the development of hypertension or stroke in SHRSP, using mainly HPLC-EC. These levels were then compared with those of SHR and WKY. The roles of the adrenal CAs in the development of hypertension and stroke were also examined. 
